Innoviva, Inc. INVA Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Cost Reimbursement | $2.1M-22.2% | $2.7M0.0% | $2.7M+92.9% | $1.4M+133% | $600K— | |
| Giapreza | $75.57M+2.7% | $73.61M+5.0% | $70.13M+7.2% | $65.45M+6.9% | $61.23M+11.3% | |
| Royalty | $233.84M-1.1% | $236.48M-3.1% | $244.1M+1.2% | $241.26M+0.1% | $241.13M-0.3% | |
| Xacduro | $84.68M+13.8% | $74.39M+51.7% | $49.04M+40.1% | $35.01M+31.5% | $26.62M+26.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Innoviva, Inc. break its business down?
- Innoviva, Inc. (INVA) reports revenue by product across 4 parts — Cost Reimbursement, Giapreza, Royalty and Xacduro. Each is extracted from the segment footnotes and tracked over time.
- Where does Innoviva, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Innoviva, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
